Vanguard Group’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Vanguard Group’s Portfolio SLGC Stock Details SLGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-8,102,144	Closed	-$20.5M	–	4546
2023 Q4	$20.5M	Buy	8,102,144 +186,455	+2%	+$434K	﹤0.01%	2586
2023 Q3	$18.9M	Buy	7,915,689 +83,139	+1%	+$184K	﹤0.01%	2570
2023 Q2	$18.1M	Buy	7,832,550 +102,342	+1%	+$289K	﹤0.01%	2633
2023 Q1	$19.7M	Buy	7,730,208 +106,633	+1%	+$306K	﹤0.01%	2589
2022 Q4	$19.1M	Buy	7,623,575 +91,819	+1%	+$256K	﹤0.01%	2649
2022 Q3	$21.8M	Buy	7,531,756 +179,274	+2%	+$755K	﹤0.01%	2589
2022 Q2	$33.2M	Buy	7,352,482 +878,592	+14%	+$5.23M	﹤0.01%	2393
2022 Q1	$51.9M	Buy	6,473,890 +3,965,138	+158%	+$35M	﹤0.01%	2287
2021 Q4	$29.2M	Buy	2,508,752 +1,844,007	+277%	+$22.1M	﹤0.01%	2641
2021 Q3	$8.24M	Buy	+664,745	New	+$7.5M	﹤0.01%	3362

Vanguard Group's SLGC Position: Q1 2024 in Review

Vanguard Group sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q1 2024, closing a stake of 8,102,144 shares — an estimated $20.5M sold.

Vanguard Group first reported a position in SLGC in Q3 2021 and held it in 10 quarters. The position peaked at $51.9M in Q1 2022. 0 funds tracked by Wall St. Rank hold SLGC as of Q1 2024.

Vanguard Group reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
Vanguard Group sold 8,102,144 SomaLogic, Inc. Class A Common Stock shares in Q1 2024, an estimated $20.5M.
Vanguard Group first reported a position in SomaLogic, Inc. Class A Common Stock in Q3 2021 and held it in 10 quarters.
Vanguard Group's SomaLogic, Inc. Class A Common Stock position peaked at $51.9M in Q1 2022.
0 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q1 2024.

Based on Vanguard Group's 13F filing for Q1 2024, filed 10 May 2024.